1079 studies found for:    Open Studies | "Colorectal Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Phase 2 Study With Abraxane (Nab®Paclitaxel) in Metastatic Colorectal Cancer
Condition: Colorectal Neoplasms
Intervention: Drug: ABI-007
22 Recruiting Presence of Circulating Tumor DNA in Colorectal Cancer
Condition: Colorectal Neoplasms
Intervention:
23 Recruiting Effectiveness of an mHealth Colorectal Cancer Screening Intervention
Condition: Colorectal Neoplasms
Interventions: Behavioral: mCRC intervention;   Behavioral: Healthy Lifestyles video
24 Recruiting Regorafenib in Frail and/or Unfit for Chemotherapy Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Neoplasms;   Metastatic Disease
Intervention: Drug: Regorafenib
25 Unknown  A Korean Post-marketing Surveillance Study on Erbitux® in Patients With Metastatic Colorectal Cancer Refractory to Irinotecan-containing Treatment
Condition: Colorectal Neoplasms
Intervention: Drug: Erbitux (Cetuximab)
26 Recruiting Regorafenib in Subjects With Metastatic Colorectal Cancer (mCRC) Who Have Progressed After Standard Therapy
Condition: Colorectal Neoplasms
Intervention: Drug: Regorafenib (BAY73- 4506)
27 Recruiting Microbiome Test for the Detection of Colorectal Polyps and Cancer
Conditions: Colorectal Neoplasms;   Colorectal Cancer
Intervention:
28 Recruiting Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Conditions: Inflammatory Bowel Disease (IBD);   Primary Sclerosing Cholangitis (PSC);   Colorectal Neoplasms;   Colorectal Cancer
Intervention:
29 Recruiting Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases
Condition: Colorectal Neoplasms
Interventions: Device: SIR-Spheres;   Drug: Regorafenib
30 Recruiting Regorafenib as Single Agent in Patients With Metastatic Colorectal Cancer (mCRC) With Any RAS or BRAF Mutation Previously Treated With FOLFOXIRI Plus Bevacizumab
Conditions: Colorectal Neoplasms;   Metastatic Disease
Intervention: Drug: Regorafenib
31 Recruiting COlorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo‑Controlled Phase-III STudy
Condition: Colorectal Neoplasms
Interventions: Drug: Regorafenib (Stivarga, BAY73-4506);   Drug: Placebo
32 Recruiting Phase I/II Trial of Antagonism of HER in GI Cancer
Conditions: Metastatic Colorectal Cancer;   Recurrent Colorectal Cancer
Interventions: Drug: AZD8931;   Drug: Irinotecan;   Drug: Folinic Acid;   Drug: Fluorouracil
33 Recruiting Brief Title : Optimized Endoscopic Submucosal Dissection With Snaring for Colorectal Neoplasm
Condition: Colorectal Neoplasms
Interventions: Procedure: Optimized ESD with snaring;   Procedure: Conventional ESD
34 Recruiting Study of Flat Polyp Detection Using New Narrow Band Imaging (NBI) Compared to White Light Colonoscopy - The FIND FLAT Colonoscopy Study
Conditions: Colorectal Neoplasms;   Colonic Polyps;   Colorectal Cancer
Intervention: Device: Technically Improved High Definition NBI Colonoscopy System
35 Recruiting Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases
Conditions: Colorectal Cancer Metastatic;   Liver Metastases;   KRAS Wild Type Colorectal Cancer
Interventions: Drug: FOLFOX6;   Biological: Bevacizumab;   Biological: Panitumumab;   Procedure: Surgery
36 Recruiting Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer
Condition: Colorectal Neoplasms
Interventions: Drug: Bevacizumab;   Drug: Capecitabine;   Drug: Levocetirizine
37 Recruiting Study of Folic Acid, Calcium and Vitamin D in Preventing Colorectal Polyps and Colorectal Cancer
Condition: Colorectal Neoplasms
Interventions: Drug: folic acid;   Drug: folic acid calcium vitamin D3;   Drug: calcium
38 Recruiting A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer
Condition: Colorectal Neoplasms
Interventions: Drug: RRx-001;   Drug: Regorafenib
39 Not yet recruiting Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver Metastases
Conditions: Colorectal Cancer Metastatic;   Liver Metastases;   KRAS Mutated Colorectal Cancer
Interventions: Drug: Modified FOLFOX6;   Biological: Aflibercept;   Procedure: Surgery
40 Recruiting Phase II Study of Maintenance Capecitabine to Treat Resectable Colorectal Cancer
Condition: Colorectal Neoplasms
Intervention: Drug: Capecitabine

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years